These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 8317473)
1. Acute myeloid leukemia presenting as granulocytic sarcoma of the lung. Wong KF; Chan JK; Chan JC; Lam SY Am J Hematol; 1993 May; 43(1):77-8. PubMed ID: 8317473 [No Abstract] [Full Text] [Related]
2. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside. Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468 [TBL] [Abstract][Full Text] [Related]
3. Primary granulocytic sarcoma of the ovary. Sreejith G; Gangadharan VP; Elizabath KA; Preetha S; Chithrathara K Am J Clin Oncol; 2000 Jun; 23(3):239-40. PubMed ID: 10857884 [TBL] [Abstract][Full Text] [Related]
4. A Case of Granulocytic Sarcoma of the Lung in Acute Myeloid Leukemia. Feng Y; Zhang L; Cheng N; Lai W; Chen Y; Liu J Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307173 [TBL] [Abstract][Full Text] [Related]
5. Intensifying induction therapy in acute myeloid leukemia by an infusional chemotherapy schedule. Friedenberg WR Cancer Invest; 1998; 16(7):542-3. PubMed ID: 9774962 [No Abstract] [Full Text] [Related]
6. Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420. Lee EJ; George SL; Caligiuri M; Szatrowski TP; Powell BL; Lemke S; Dodge RK; Smith R; Baer M; Schiffer CA J Clin Oncol; 1999 Sep; 17(9):2831-9. PubMed ID: 10561359 [TBL] [Abstract][Full Text] [Related]
7. No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group. Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Kanamaru A; Oh H; Ohtake S; Asou N; Sakamaki H; Yamada O; Jinnai I; Tsubaki K; Takeyama K; Hiraoka A; Matsuda S; Takahashi M; Shimazaki C; Adachi K; Kageyama S; Ohno R Int J Hematol; 1999 Aug; 70(2):97-104. PubMed ID: 10497848 [TBL] [Abstract][Full Text] [Related]
8. CD7 expression does not predict for poor outcome in acute myeloblastic leukemia. Pillay Y; McLellan G; Davison G; Kelly S; Jacobs P Blood; 1995 Jun; 85(11):3357-9. PubMed ID: 7538826 [No Abstract] [Full Text] [Related]
9. Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study. Farag SS; Ruppert AS; Mrózek K; Mayer RJ; Stone RM; Carroll AJ; Powell BL; Moore JO; Pettenati MJ; Koduru PR; Stamberg J; Baer MR; Block AW; Vardiman JW; Kolitz JE; Schiffer CA; Larson RA; Bloomfield CD J Clin Oncol; 2005 Jan; 23(3):482-93. PubMed ID: 15534356 [TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults. Kolitz JE; George SL; Baer MR; Lee EJ; Bloomfield CD; Larson RA; Ann Hematol; 2004; 83 Suppl 1():S103-4. PubMed ID: 15124695 [No Abstract] [Full Text] [Related]
11. [The results of 2 and 1/2 years of work of the Russian Multicenter Trial on the Treatment of Acute Myeloid Leukemias in Adults]. Savchenko VG; Parovichnikova EN; Gliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS Ter Arkh; 1995; 67(7):8-12. PubMed ID: 7482315 [No Abstract] [Full Text] [Related]
14. New agents in the treatment of acute myeloid leukemia. Wiernik PH Semin Hematol; 1991 Jul; 28(3 Suppl 4):95-8. PubMed ID: 1780763 [No Abstract] [Full Text] [Related]
15. [The current chemotherapy of acute myeloid leukemias in adults]. Poddubnaia IV; Perilov AA Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791 [No Abstract] [Full Text] [Related]
16. [An unusual way of manifesting acute granulocytic leukemia: granulocytic sarcoma of the breast. Apropos of a case with trisomy 22]. Turpin F; Trassard M; Bourguignat A; Floiras JL; Le Doussal V; Eydoux P Nouv Rev Fr Hematol (1978); 1986; 28(2):91-6. PubMed ID: 3461426 [TBL] [Abstract][Full Text] [Related]
17. Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621. Kolitz JE; George SL; Dodge RK; Hurd DD; Powell BL; Allen SL; Velez-Garcia E; Moore JO; Shea TC; Hoke E; Caligiuri MA; Vardiman JW; Bloomfield CD; Larson RA; J Clin Oncol; 2004 Nov; 22(21):4290-301. PubMed ID: 15514371 [TBL] [Abstract][Full Text] [Related]
19. Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: a review and updated results of the Australian Leukemia Study Group. Bishop JF; Matthews JP; Young GA; Bradstock K; Lowenthal RM Leuk Lymphoma; 1998 Jan; 28(3-4):315-27. PubMed ID: 9517503 [TBL] [Abstract][Full Text] [Related]
20. [The results of a multicenter cooperative study on treating acute myeloid leukemias in adults]. Savchenko VG; Parovichnikova EN; Kliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS Ter Arkh; 1994; 66(7):11-7. PubMed ID: 7985120 [No Abstract] [Full Text] [Related] [Next] [New Search]